Applied DNA Sciences Expands Cash in Transit Product into Poland-CBZ Integrates SigNature® DNA into New Cash Carrying Case

Share Article

The expansion into Poland follows significant success in the battle against cash in transit attacks in the United Kingdom and other European countries

News Image

Applied DNA Sciences (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, today announced that, in conjunction with Centralne Biuro Zabezpieczeń (CBZ) of Poland, the company is about to introduce its award-winning SigNature® DNA forensic anti-theft product into Poland.

The expansion into Poland follows significant success in the battle against cash in transit attacks in the United Kingdom and other European countries.

CBZ, a leading manufacturer and supplier of security products across Poland have has developed a new cash carrying case containing inks that trigger in the event of an attack, covering the bank notes and perpetrators with an indelible ink containing SigNature DNA. Each cash case contains a different and unique DNA mark enabling law enforcement agencies to forensically link suspects and valuables back to the individual cash box and crime.

SigNature DNA has already helped law enforcement agencies convict 71 criminals for involvement in cash in transit and related crime who have received prison sentences of 345 years, with many more cases in the pipeline.

CBZ will officially launch the new cash case at the Securex International Fair in Poznań, Poland during April 8 – 11, 2014 and aims to sell at least 1,000 units in the first year.

CBZ has an impressive list of clients who include the largest cash in transit and security companies in Poland, the major banks, the army, police and Polish Post Office.

CBZ issued this statement:

“CBZ has been operating, producing and manufacturing security products for the CIT business since 1995 and have always been looking for solutions which will provide the greatest deterrent to attacks on personnel, cash and documents.

"Recently, we have been working with Applied DNA Sciences to bring the next generation of CIT security to the Polish market. SigNature DNA is the next generation which uses botanical DNA; complex in its coding but simple to add into the production process. Any business wanting to protect their personnel and assets should be using SigNature DNA, not only as the ultimate deterrent but also as concrete evidence in achieving criminal convictions should an attack occur.

We look forward to working with Applied DNA Sciences now and in the future and know our customers will benefit not only from having the ultimate CIT security deterrent now on the market but also from further future innovations.”

Tony Benson of APDN said, “CBZ is a highly innovative and well respected supplier of security products and solutions within Poland, supplying very prestigious clients. It has been a pleasure to work with CBZ in adding SigNature DNA to their new cash case and we look forward to continuing our relationship.”

About Applied DNA Sciences:

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and DNANet, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2013 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mitchell Miller

Debbie Bailey
Visit website